Recent insights into vitamin D and its receptor

Journal of Nephrology

Volumn 24, Issue SUPPL. 18, 2011, Pages 30-37

  Messa, Piergiorgio ^a   Alferi, Carlo ^a   Rastaldi, Maria Pia ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Calcium; Chronic kidney disease; Parathyroid hormone; Vitamin d; Vitamin d receptor

Indexed keywords

CALCITRIOL; CALCIUM; CALCIUM SENSING RECEPTOR; CYTOCHROME P450; CYTOCHROME P450 24A1; CYTOCHROME P450 27B1; DRUG METABOLITE; GENOMIC DNA; MESSENGER RNA; PARATHYROID HORMONE; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

AUTOCRINE EFFECT; BONE MINERALIZATION; CALCIUM ABSORPTION; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CHRONIC KIDNEY DISEASE; DRUG RECEPTOR BINDING; ELECTROLYTE DISTURBANCE; ENZYME REGULATION; GENE FUNCTION; GENETIC VARIABILITY; GENOME ANALYSIS; HORMONAL REGULATION; HORMONE SYNTHESIS; HUMAN; HYPERPARATHYROIDISM; NONHUMAN; PARACRINE SIGNALING; PARATHYROID FUNCTION; RECEPTOR GENE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN D RECEPTOR GENE; VITAMIN D RESPONSIVE ELEMENT;

BONE DISEASES, METABOLIC; CHRONIC DISEASE; HUMANS; KIDNEY DISEASES; MINERALS; PARATHYROID HORMONE; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 79958744431     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/JN.2011.7767     Document Type: Review

References (43)

1. Parftt AM, Gallagher JC, Heaney R P, et al. Vitamin D and bone health in the elderly. Am J Clin Nutr. 1982; 36:1014-1031.
2. Verstuyf A, Carmeliet G, Bouillon R, Mathieu C. Vitamin D: a pleiotropic hormone. Kidney Int. 2010; 78:140-145.
3. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006; 81:353-373.
4. Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol. 2008; 3:1535-1541.
5. DeLuca HF. Evolution of our understanding of vitamin D. Nutrition Rev. 2008; 66:S73-S87.
6. Holick M F. Vitamin D defciency. New Eng J Med. 2007; 357:266-281.
7. Nykjaer A, Dragun D, Walther D et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell. 1999; 96:507-551.
8. Shimada T, Kakitani M, Yamazaki Y et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004; 113:561-568.
9. Urakawa I, Yamazaki Y, Shimada T et al. Klotho converts canonical FGF receptor into a specifc receptor for FGF23. Nature. 2006; 444:770-774.
10. Verstuyf A, Carmeliet G, Bouillon R, Mathieu C. Vitamin D: a pleiotropic hormone. Kidney Int. 2010; 78:140-145.
11. Wang XX, Jiang T, Shen Y, et al. The vitamin D receptor agonist doxercalciferol modulates dietary fat induced renal disease and renal lipid metabolism. Am J Physiol Renal Physiol. 2011 Jan 5. [Epub ahead of print].
12. Li YC. Renoprotective effects of vitamin D analogs. Kidney Int. 2010; 78:134-139.
13. Plum LA, DeLuca H F. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov. 2010; 9:941-955.
14. Dusso AS, Tokumoto M. Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotec-tion: a downward spiral in kidney disease. Kidney Int. 2011 Jan 26. [Epub ahead of print].
15. Dusso A, Brown A, Slatopolsky E. Extrarenal production of calcitriol. Semin Nephrol. 1994; 14:144-155.
16. Zehnder D, Bland R, Williams MC, et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab. 2001; 86:888-894.
17. Anderson PH, Iida S, Tyson JH, Turner AG, Morris HA. Bone CYP27B1 gene expression is increased with high dietary calcium and in mineralizing osteoblasts. J Steroid Biochem Mol Biol. 2010; 121:71-75.
18. Ramagopalan SV, Heger A, Berlanga AJ, et al. A ChIP-seq defned genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010; 20:1352-1360.
19. Haussler MR, Haussler CA, Whitfeld GK, et al. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging. J Steroid Biochem Mol Biol. 2010; 121:88-97.
20. DeLuca H F, Plum LA, Clagett-Dame M. Selective analogs of 1alpha,25-dihydroxyvitamin D3 for the study of spe-cifc functions of Vitamin D. J Steroid Biochem Mol Biol. 2007; 103:263-268.
21. Zhang J, Chalmers MJ, Stayrook KR, et al. Hydrogen/deuterium exchange reveals distinct agonist/partial agonist receptor dynamics within vitamin D receptor/retinoid X receptor heterodimer. Structure. 2010; 18:1332-1341.
22. Nemere I, Yoshimoto Y, Norman AW. Calcium transport in perfused duodena from normal chicks: enhancement within fourteen minutes of exposure to 1,25-dihydroxyvitamin D3. Endocrinology. 1984; 115:1476-1483.
23. Mizwicki MT, Norman AW. The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Sci Signal. 2009; 2. Epub ahead of print.
24. Nemere I, Safford SE, Rohe B, DeSouza MM, Farach-Carson MC. Identifcation and characterization of 1,25D3-membrane-associated rapid response, steroid (1,25D3-MARRS) binding protein. J Steroid Biochem Mol Biol. 2004; 89-90:281-285.
25. Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006; 147:5542-5548.
26. Costa JL, Eijk P P, van de Wiel MA, et al. Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knockdown. BMC Genomics. 2009; 10:499. Epub ahead of print.
27. Chen J, Olivares-Navarrete R, Wang Y, Herman TR, Boyan BD, Schwartz Z. Protein-disulfde isomerase-associated 3 (Pdia3) mediates the membrane response to 1,25-dihydroxyvitamin D3 in osteoblasts. J Biol Chem. 2010; 285:37041-37050.
28. Wang Y, Chen J, Lee CS, et al. Disruption of Pdia3 gene results in bone abnormality and affects 1alpha,25-dihydroxy-vitamin D3-induced rapid activation of PKC. J Steroid Bio-chem Mol Biol. 2010; 121:257-260.
29. Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest. 1986; 78:1296-1301.
30. Canaff L, Hendy GN. Human calcium-sensing receptor gene: vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem. 2002; 277:30337-30350.
31. Meir T, Levi R, Lieben L, et al. Deletion of the vitamin D receptor specifcally in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology. Am J Physiol Renal Physiol. 2009; 297:F1192-F1198.
32. Xue Y, Fleet JC. Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice. Gastroenterol. 2009; 136:1317-1327.
33. Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from vitamin D receptor alleles. Nature. 1994; 367:284-287.
34. Muray S, Parisi E, Cardús A, Craver L, Fernández E. Influence of vitamin D receptor gene polymorphisms and 25-hy-droxyvitamin D on blood pressure in apparently healthy subjects. J Hypertens. 2003; 21:2069-2075.
35. Filus A, Trzmiel A, Kuliczkowska-Płaksej J, et al. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male. 2008; 11:134-139.
36. Testa A, Mallamaci F, Benedetto FA, et al. Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients. J Bone Miner Res. 2010; 25:313-319.
37. Ortlepp JR, Krantz C, Kimmel M, et al. Additive effects of the chemokine receptor 2, vitamin D receptor, interleukin-6 polymorphisms and cardiovascular risk factors on the prevalence of myocardial infarction in patients below 65 years. Int J Cardiol. 2005; 105:90-95.
38. Chiu KC, Chuang LM, Yoon C. The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians. BMC Med Genet. 2001; 2:2. Epub ahead of print.
39. Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism. 2002; 51:356-359.
40. Carling T, Kindmark A, Hellman P, et al. Vitamin D receptor genotypes in primary hyperparathyroidism. Nat Med. 1995; 1:1309-1311.
41. Messa P, Sindici C, Cannella G, et al. Persistent secondary hyperparathyroidism after renal transplantation. Kidney Int. 1998; 54:1704-1713.
42. Köstner K, Denzer N, Müller CS, Klein R, Tilgen W, Reichrath J. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009; 29:3511-3536.
43. de Jongh RT, Lips P, Rijs KJ, et al. Associations between vitamin D receptor genotypes and mortality in a cohort of older Dutch individuals. Eur J Endocrinol. 2011; 164:75-82.